Emily A Sloan, MD, PhD| Clinical And Laboratory Pathology, Pathology | MedStar Health
About me
Emily A. Sloan, MD, PhD, is Associate Director of Neuropathology at the MedStar Comprehensive Brain Tumor Center and Department of Pathology at MedStar Georgetown University Hospital. As a diagnostic neuropathologist, her clinical focus is on diseases of the central nervous system, with an emphasis on neoplastic disease and the grading and classification of CNS tumors. She also has expertise in neuromuscular pathology and autopsy pathology. She is triple board certified in Neuropathology, Anatomic Pathology, and Clinical Pathology.
Dr. Sloan is a member of multiple societies including the American Association of Neuropathologists, College of American Pathologists, and United States and Canadian Academy of Pathology. She has published more than 25 basic science and translational research studies in peer-reviewed journals. With this knowledge, she integrates histopathologic classification and molecular informatics to ensure her patients receive the best possible diagnostic care.
Dr. Sloan also actively participates in education of residents, fellows, and medical students, receiving a teaching award for Resident Education. She earned her Ph.D in Microbiology, Immunology and Cancer Biology investigating the molecular genetics of HIV infection, and maintains a strong interest in infectious diseases and health equity.
Dr. Sloan’s main areas of clinical expertise include:
- Expert diagnostic services in neuro-oncology, inflammatory/autoimmune disease, infectious processes, muscle and nerve disorders, and neurodegenerative disease
- Rapid intraoperative consultations
- Post-mortem neuropathologic brain examinations, including evaluation of neurodegenerative diseases, as well as general autopsy services
- Ancillary techniques including histochemistry, immunohistochemistry, ultrastructural evaluation, and molecular genetics for integrated tumor classification
Conditions and procedures
Conditions I treat
- Acoustic Neuroma
- Anaplastic Astrocytoma
- Anaplastic Ependymoma
- Arachnoid Cyst
- Benign Neoplasm Of Brain
- Brain And Spine Tumors
- Brain Neoplasms
- Cavernous Hemangioma
- Central Nervous System Abscess
- Central Nervous System Infection
- Central Nervous System Malignancy
- Central Nervous System Tumors
- Cerebral Anomalies
- Cerebral Hemorrhage
- Clivus Chondroma
- Demyelinating Disease
- Dural Based Tumor
- Embryonal Cell Tumors Of The Brain
- Embryonal Tumors
- Endodermal Sinus Tumor
- Ganglioneuroblastoma
- Genetic Disorders
- Glioblastoma Multiforme
- Leptomeningeal Carcinomatosis
- Malignant Brain Neoplasm
- Malignant Neoplasm Of Brain Stem
- Malignant Neoplasm Of The Spinal Cord
- Medulloepithelioma
- Meningioma
- Metastatic Brain Cancer
- Muscular Dystrophy
- Nasopharyngeal Angiofibroma
- Neuroendocrine Tumors
- Rhabdoid Tumor Predisposition Syndrome
- Spinal Cord Tumors
- Tuberous Sclerosis
- Turcot Syndrome
- Vertebral Hemangioma
- Von Hippel Lindau Disease
Procedures I perform
- Autopsy
- Brain Cancer Genomics
- Cancer Genetics
- Cytopathology Evaluation Of Fine Needle Aspirate
- Immunogenetics
- Next Generation Sequencing
- Tumor Pathology
- Whole Genome Sequencing
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- CareFirst Group Medicare Advantage
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- Cigna Choice Fund PPO
- Carefirst BlueChoice Opt Out Open Access
- Carefirst Blue Preferred PPO
- Innovation Health: Open Network Only Plus
- United Golden Rule
- WellPoint Maryland
- United Mamsi Life & Health
- WellPoint Maryland - Maryland Health Choice
- United Core Essential (HMO)
- Anthem HMO - BCBS of VA HealthKeepers
- United Options (PPO) (includes Empire PPO)
- Cigna Achieve Medicare (HMO C-SNP)
- Cigna True Choice Plus Medicare (PPO)
- Innovation Health: HMO & EPO Plus
- Kaiser Maryland Medicaid MCO
- Medicaid - Virginia
- Veterans Affairs Community Care Network (VA CCN)
- United Student Resources
- Innovation Health: POS Plus
- Aetna Choice POS & Choice POS II
- Cigna Alliance Medicare (HMO) |
- Aetna Traditional Choice (PPO)
- United Nursing Home Plan (C-SNP
- Medicaid - District of Columbia
- Carefirst EPO
- Cigna Indemnity
- United Select HMO - EPO/NPP
- Cigna POS/Network POS
- Tricare Reserve Select
- United Choice Plus
- Carefirst BlueChoice HMO
- Kaiser Medicare Plus
- Aetna Student Health Insurance
- Aetna HealthFund/Health Network Option OA
- CareFirst (NCA) Indemnity
- United Choice
- Veterans Affairs Community Care Network
- CIGNA EPO
- United MD IPA (HMO)
- Kaiser Signature
- Kaiser Permanente Signature-Added Choice
- Aetna Managed Choice Open Access (POS)
- UnitedHealthcare Individual Exchange Plans
- United Community Plan - Maryland Health Choice Program
- United GEHA (for all other states) Compass Rose
- Tricare East Prime
- Carefirst BlueChoice Open Access
- Kaiser HMO Plus and DHMO Plus Member
- CareFirst NASCO
- Private Health Care Systems (PHCS) (PPO)
- Medicaid - Maryland
- Kaiser Select-Added Choice
- United Medicare Advantage DSNP District of Columbia
- Cigna TotalCare (HMO D-SNP)
- Aetna Signature Administrator PPO/TPA
- Tricare East Select
- HealthyBlue PPO
- Cigna HMO & Network (HMO)
- Aetna Managed Choice (POS)
- Carefirst Healthy Blue (HMO/POS)
- Cigna POS Open Access & Open Access Plus
- Kaiser Flexible Choice
- Tricare for Life East
- Cigna True Choice Medicare (PPO)
- Carefirst BlueChoice Opt Out Plus Open Access (POS)
- Cigna Preferred Medicare
- Aetna HMO
- MedStar Family Choice DC Healthy Families
- Anthem Plus BCBS of VA HealthKeepers Plus
- United Erickson Advantage Plans
- Innovation Health: Indemnity
- Aetna Open Choice (PPO)
- CareFirst Blue Card Program (Out-of-area BCBS plans)
- Innovation Health: Open POS II
- Aetna Quality Point of Service (POS)
- United Select Plus (POS)
- Innovation Health: Open POS Plus
- CareFirst MedStar Select PPO
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- United Navigate
- CareFirst BC/BS Advantage Core/Enhanced
- Virginia Premier
- HumanaChoice PPO
- United Optimum Choice
- MedStar Family Choice DC Healthcare Alliance
- CareFirst MedStar PPO
- Beech Street PPO
- Kaiser Medicare Advantage Signature and Select
- Aetna HMO-Open Access/Select OA
- Police and Fire Clinic
- Federal Employee Program (Std/Basic PPO/Blue Focus)
- Aetna Medicare Advantage HMO & PPO Plans
- Innovation Health: Network Only Plus
- United Group Medicare Advantage Plans
- Traditional Medicare Fee for Service
- Aetna Select HMO/HealthFund/Health Network
- United AARP Medicare Complete
- Aetna Elect Choice/ Open Access (POS)
- Kaiser Select
- Health Services for Children with Special Needs (HSCSN)
- D-SNP)
- Cigna PPO and PPO Plus
- Aetna Open HMO/Open HMO Option/Open EPO Plus
- HumanaChoice Honor’s plan PPO
- Cigna HMO Open Access
- Anthem (POS & Open Access POS) BCBS of VA HealthKeepers
- CareFirst Maryland Indemnity or PPO
- United Optimum Choice Preferred (POS) & OCI Direct (HMO)
- United MD IPA Preferred (POS)
- Cigna Network Open Access
- CareFirst Administrators
- Innovation Health: POS
- Maryland Point of Service Plan (MPOS)
- Choice Care Network/HUMANA (PPO)
- Innovation Health: PPO
- I-SNP
- MedStar Family Choice - Maryland Health Choice
- Coventry Health Care National Network PPO
- First Health PPO
- Coventry of Delaware HMO/PPO
- Coventry Health Care of Virginia
- Great-West Healthcare POS/CIGNA
Education
Board Certification: American Board of Pathology, Anatomic Pathology
Board Certification: American Board of Pathology, Clinical Pathology
Board Certification: American Board of Pathology, Neuropathology
Fellowship Program: University of California San Francisco (2020)
Residency Program: University of Virginia Hospitals (2018)
Medical School: University of Virginia School of Medicine (2014)
Awards
- Resident Teaching Award, MedStar Georgetown Department of Pathology (2022)
- Moore Award for best clinico-pathologic paper in neuropathology, American Association of Neuropathologists (AANP) (2020)
- O.T. Bailey-Helena Riggs Award, AANP Diagnostic Slide Session (2019)
Hospital affiliations
News and publications
- Sloan EA, Gupta R, Koelsche C, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Reddy A, Mueller S, Cho SJ, Horvai AE, Lee JC, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, von Deimling A, Chang SM, Berger MS, Solomon DA. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathol. 2022 Jul;32(4):e13037. doi: 10.1111/bpa.13037. Epub 2021 Nov 25. PMID: 34821426; PMCID: PMC9245938.
- Sloan EA, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Raffel C, Berger MS, Chang SM, Reddy A, Ramani B, Ferris SP, Lee JC, Hofmann JW, Cho SJ, Horvai AE, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, Solomon DA. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathol. 2021 Jul;31(4):e12918. doi: 10.1111/bpa.12918. Epub 2021 Jan 28. PMID: 33141488; PMCID: PMC8089120.
- Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, Samuel D, Brown M, Carmichael J, Lu R, Mirchia K, Sullivan DV, Pekmezci M, Tihan T, Bollen AW, Perry A, Banerjee A, Mueller S, Gupta N, Hervey-Jumper SL, Oberheim Bush NA, Daras M, Taylor JW, Butowski NA, de Groot J, Clarke JL, Raleigh DR, Costello JF, Phillips JJ, Reddy AT, Chang SM, Berger MS, Solomon DA. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol. 2022 Oct;144(4):747-765. doi: 10.1007/s00401-022-02478-5. Epub 2022 Aug 9. PMID: 35945463; PMCID: PMC9468105.
- Yeh J, Marks JA, Alzeer AH, Sloan EA, Varghese R, Paudel N, Reuss JE, Bergquist PJ, Liu SV, Kim C. Remarkable Intracranial Response to Sotorasib in a Patient With KRASG12C-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case Report. JTO Clin Res Rep. 2022 Nov 6;3(12):100428. doi: 10.1016/j.jtocrr.2022.100428. PMID: 36471683; PMCID: PMC9719091.
- Alonzo CJ, Burnsed JC, Sloan EA, Zanelli SA. A Term Infant with Encephalopathy and Severe Leukocytosis. Neoreviews. 2022 Aug 1;23(8):e579-e581. doi: 10.1542/neo.23-8-e579. PMID: 35909106.
- Mehta A, Khan F, Wagner C, Hashemzadeh T, Stemer A, Sloan EA, Mayson D, Amjad F. A Case of Neurosarcoid Presenting as Multiple Intraparenchymal Hemorrhages. Neurohospitalist. 2022 Jan;12(1):162-166. doi: 10.1177/19418744211029495. Epub 2021 Jun 30. PMID: 34950407; PMCID: PMC8689526.
- Pekmezci M, Morshed RA, Chunduru P, Pandian B, Young J, Villanueva-Meyer JE, Tihan T, Sloan EA, Aghi MK, Molinaro AM, Berger MS, Hervey-Jumper SL. Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology. Sci Rep. 2021 Jun 9;11(1):12162. doi: 10.1038/s41598-021-91648-8. PMID: 34108566; PMCID: PMC8190264.
- Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, M Chang S, Berger MS, Solomon DA, Perry A. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathol. 2020 Dec;140(6):907-917. doi: 10.1007/s00401-020-02221-y. Epub 2020 Sep 6. PMID: 32892244; PMCID: PMC7682537.
- Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, M Chang S, Berger MS, Solomon DA, Perry A. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathol. 2020 Dec;140(6):907-917. doi: 10.1007/s00401-020-02221-y. Epub 2020 Sep 6. PMID: 32892244; PMCID: PMC7682537.
- Sloan EA, Sampognaro PJ, Junn JC, Chin C, Jacques L, Ramachandran PS, DeRisi JL, Wilson MR, Kriegstein AR, Bollen AW, Solomon DA, Margeta M, Engstrom JW. Neuroglial stem cell-derived inflammatory pseudotumor (n-SCIPT): clinicopathologic characterization of a novel lesion of the lumbosacral spinal cord and nerve roots following intrathecal allogeneic stem cell intervention. Acta Neuropathol. 2019 Dec;138(6):1103-1106. doi: 10.1007/s00401-019-02089-7. Epub 2019 Oct 28. PMID: 31659431; PMCID: PMC6858593.
- Sloan EA, Cooney T, Oberheim Bush NA, Buerki R, Taylor J, Clarke JL, Torkildson J, Kline C, Reddy A, Mueller S, Banerjee A, Butowski N, Chang S, Mummaneni PV, Chou D, Tan L, Theodosopoulos P, McDermott M, Berger M, Raffel C, Gupta N, Sun PP, Li Y, Shah V, Cha S, Braunstein S, Raleigh DR, Samuel D, Scharnhorst D, Fata C, Guo H, Moes G, Kim JYH, Koschmann C, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Pekmezci M, Phillips JJ, Tihan T, Bollen AW, Perry A, Solomon DA. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. Acta Neuropathol. 2019 Nov;138(5):877-881. doi: 10.1007/s00401-019-02072-2. Epub 2019 Sep 12. PMID: 31515627; PMCID: PMC6818961.
- Sloan EA, Hilz S, Gupta R, Cadwell C, Ramani B, Hofmann J, Kline CN, Banerjee A, Reddy A, Oberheim Bush NA, Chang S, Braunstein S, Chang EF, Raffel C, Gupta N, Sun PP, Kim JYH, Moes G, Alva E, Li R, Bruggers CS, Alashari M, Wetmore C, Garg S, Dishop M, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Phillips JJ, Pekmezci M, Tihan T, Bollen AW, Berger MS, Costello JF, Perry A, Solomon DA. Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features. Acta Neuropathol. 2020 May;139(5):953-957. doi: 10.1007/s00401-020-02144-8. Epub 2020 Mar 10. PMID: 32157385; PMCID: PMC7183424.